Latham & Watkins represented KKR, while Goodwin Procter advised NetSPI in the transaction. NetSPI, a leader in enterprise penetration testing and attack surface management, announced that...
KKR’s $410 Million Investment in NetSPI
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
DigitalBridge Investment Management and IFM’s $11 Billion Take-Private Acquisition of Switch
Latham & Watkins advised the Special Committee of the Board of Directors of Switch, and Simpson Thacher & Bartlett advised DigitalBridge and IFM on the deal....
Chevron’s $3.15 Billion Acquisition of Renewable Energy Group
Paul, Weiss, Rifkind, Wharton & Garrison and Shearman & Sterling represented Chevron, while Latham & Watkins represented Renewable Energy Group in the transaction. Chevron Corporation (NYSE: CVX)...
Oracle’s $28.3 Billion Acquisition of Cerner
Latham & Watkins represented Cerner in the transaction. Hogan Lovells advised Oracle Corporation. Fried Frank acted as counsel to Goldman Sachs and Centerview Partners as financial...
Highgate and Cerberus’ $1.5 Billion Acquisition of CorePoint Lodging
Simpson Thacher represented CorePoint Lodging in the transaction. Kirkland & Ellis and Latham & Watkins advised the joint venture between Cerberus Capital Management, L.P. and affiliates...
Meta’s Acquisition of Within
Cooley LLP advised Within on the deal. Within, a Los Angeles-based firm responsible for developing immersive virtual reality fitness app Supernatural, announced its agreement to sell to...
Procept BioRobotics’ $163.9 Million Initial Public Offering
Latham & Watkins represented PROCEPT in the transaction. PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology,...
Tyra Biosciences’ $172.8 Million Initial Public Offering
Latham & Watkins represented Tyra Biosciences in the offering while Sidley advised the underwriters. Tyra Biosciences, Inc. has announced the pricing of its upsized initial public offering of...
Environmental Impact’s Business Combination with GreenLight Biosciences
Foley Hoag represented GreenLight., while Latham & Watkins represented Environmental Impact Acquisition Corp. in the transaction. GreenLight Biosciences, Inc., a biotechnology company dedicated to making ribonucleic acid...
Ginger’s Merger with Headspace
Wilson Sonsini Goodrich & Rosati advised Ginger on the deal, while Latham & Watkins represented Headspace. Ginger, a leading provider of on-demand mental healthcare, and Headspace, a...
Icosavax’s $209.3 Million IPO
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...